Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

17.08
+1.7311.24%
Post-market: 17.01-0.0650-0.38%17:59 EDT
Volume:727.24K
Turnover:12.29M
Market Cap:224.58M
PE:-2.84
High:17.50
Open:15.95
Low:15.36
Close:15.35
52wk High:17.50
52wk Low:3.39
Shares:13.15M
Float Shares:12.46M
Volume Ratio:2.92
T/O Rate:5.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0077
EPS(LYR):-7.9367
ROE:-90.25%
ROA:-32.01%
PB:2.15
PE(LYR):-2.15

Loading ...

OverviewCompanyNewsFilings

Press Release: Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

Dow Jones
·
Jun 18

Avalo Therapeutics Inc. Conducted Annual Meeting of Shareholders

Reuters
·
Jun 18

Avalo Therapeutics Inc. Enters $75 Million Sales Agreement with TD Cowen for Common Stock Offering

Reuters
·
Jun 06

Avalo Therapeutics Inc. Unveils Presentation Highlighting Advancements in Targeted Therapies for Immune Mediated Inflammatory Diseases

Reuters
·
Jun 04

Avalo Therapeutics Q1 2025 EPS $(1.25) Beats $(1.39) Estimate, Cash On Hand Of Approximately $125 As Of March 31, 2025 Expected To Provide Runway Into 2027, With Optionality To Extend Into 2028

Benzinga
·
May 12

Press Release: Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

Dow Jones
·
May 12

Avalo Therapeutics Inc expected to post a loss of $1.39 a share - Earnings Preview

Reuters
·
May 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 07, 2025 Pre-Market
Financial Report Announcement
May 12, 2025 Pre-Market
Financial Report Announcement
Mar 20, 2025 Pre-Market
Financial Report Announcement
Nov 07, 2024 Pre-Market
Financial Report Announcement
Aug 12, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.84
Current
-2.83
Sector Average
20.50%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.84
Maximum
1.17
+1 STD
0.87
Minimum
-17.38
-1 STD
-6.52
Average
-2.83

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.